Presentation TCT 2017 TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID Presenter: Kurt Huber, Jamil Abdalla Saad, Antonio Gutierrez, MD October 31, 2017
Presentation TCT 2017 TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe October 31, 2017
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism Presenter: Kurt Huber, Jamil Abdalla Saad, Kara Denby, MD October 31, 2017
Presentation TCT 2017 TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD October 31, 2017
Presentation TCT 2017 TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry Presenter: Kurt Huber, Jamil Abdalla Saad, Sabato Sorrentino, MD October 31, 2017
Presentation EuroPCR 2017 Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial Presenter: Lucas Boersma, Martin W. Bergmann May 18, 2017